CELZ-201-DDT

· Creative Medical Technology Holdings Inc

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CELZ-201-DDT, covering 2025-08-22 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back Pain [Phase 1, Phase 2]

See pricing